Data as of Jan 23
| +0.13 / +3.13%|
The 5 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 10.00, with a high estimate of 34.00 and a low estimate of 7.00. The median estimate represents a +133.64% increase from the last price of 4.28.
The current consensus among 5 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.